Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients

NCT02707263 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: intravenous continuous infusion of heparin (IV UFH)
DRUG: Subcutaneous Heparin

Sponsor

NYU Langone Health